May 8, 2017 ... Plaintiff appealed the district court's grant of summary judgment in favor of her former employer, AstraZeneca Pharmaceutical LP, on Plaintiff's ...
May 2, 2017 ... ASTRAZENECA PHARMACEUTICAL LP ASTRAZENECA LP. ... TAYMARI DELGADO ECHEVARRÍA, Plaintiff, Appellant, v. ... As in all other summary- judgment cases, we view the facts (and all reasonable .... See Reed v.
Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...
blaming GlaxoSmithKline for the suicide of a Reed Smith partner who had been taking a generic. ... ASTRAZENECA PHARMACEUTICALS LP et al ... May 16, 2018 | 87648954 GlaxoSmithKline Intellectual Property Limited v H Lundbeck A S.
ALLERGAN, INC., ET AL, case number 2:08-cv-05135, from Pennsylvania Eastern Court. ... STRECK v. ... ASTRAZENECA PHARMACEUTICALS LP ...
VERSUS. NO: 15-438. ASTRAZENECA PHARMECEUTICALS,. LP, ET AL. SECTION: J(2) ... Pharmaceuticals, LP (“AstraZeneca”), and an Opposition thereto. (Rec. Doc. ... of all Plaintiff's claims pursuant to Federal Rule of Civil. Procedure ... Taylor v. Books A. Million, Inc., 296 F.3d 376, 378 (5th Cir. 2002) ( citing. McConathy ...
Feb 2, 2018 ... Defendants Astrazeneca. Pharmaceuticals LP, Bristol-Myers Squibb Co., and McKesson Corp. oppose centralization and, alternatively, suggest .... REID v. BRISTOL!MEYERS SQUIBB COMPANY, ET AL., C.A. No. 1:17!01503.
May 31, 2007 ... v. Lek Pharmaceutical and Chemical Co., D.D., et al., Defendants. ...... AstraZeneca, LP holds an approved New Drug Application from the United States Food ..... and citations omitted)), its subjectivity, Highland Capital Mgmt., L.P. v. ..... After receiving his Ph.D., Dr. Christian worked at the Walter Reed Army ...
effects attributed to pharmaceuticals in environmental waters. ... 4 Murray-smith et al (2012) Managing emissions of active pharmaceutical ingredients from.